Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC929028093;28094;28095 chr2:178711962;178711961;178711960chr2:179576689;179576688;179576687
N2AB897327142;27143;27144 chr2:178711962;178711961;178711960chr2:179576689;179576688;179576687
N2A804624361;24362;24363 chr2:178711962;178711961;178711960chr2:179576689;179576688;179576687
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACT
  • RefSeq wild type template codon: TGA
  • Domain: Ig-78
  • Domain position: 86
  • Structural Position: 172
  • Q(SASA): 0.1514
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/A rs1256283190 None 0.004 N 0.263 0.105 0.12205267543 gnomAD-4.0.0 1.62297E-06 None None None None N None 0 2.33634E-05 None 0 0 None 0 0 0 0 0
T/S rs1196673354 -1.29 0.043 N 0.291 0.093 0.184867976434 gnomAD-2.1.1 4.14E-06 None None None None N None 0 2.97E-05 None 0 0 None 0 None 0 0 0
T/S rs1196673354 -1.29 0.043 N 0.291 0.093 0.184867976434 gnomAD-4.0.0 1.62302E-06 None None None None N None 0 2.33754E-05 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.0565 likely_benign 0.0717 benign -1.032 Destabilizing 0.004 N 0.263 neutral N 0.399854625 None None N
T/C 0.2861 likely_benign 0.3906 ambiguous -0.49 Destabilizing 0.992 D 0.748 deleterious None None None None N
T/D 0.6637 likely_pathogenic 0.7994 pathogenic -0.781 Destabilizing 0.816 D 0.776 deleterious None None None None N
T/E 0.6849 likely_pathogenic 0.8269 pathogenic -0.588 Destabilizing 0.816 D 0.763 deleterious None None None None N
T/F 0.5252 ambiguous 0.7542 pathogenic -0.674 Destabilizing 0.969 D 0.795 deleterious None None None None N
T/G 0.2112 likely_benign 0.2697 benign -1.454 Destabilizing 0.69 D 0.719 prob.delet. None None None None N
T/H 0.5122 ambiguous 0.7197 pathogenic -1.457 Destabilizing 0.997 D 0.769 deleterious None None None None N
T/I 0.3201 likely_benign 0.5147 ambiguous 0.073 Stabilizing 0.922 D 0.793 deleterious N 0.482531936 None None N
T/K 0.603 likely_pathogenic 0.7811 pathogenic -0.223 Destabilizing 0.816 D 0.768 deleterious None None None None N
T/L 0.1965 likely_benign 0.3775 ambiguous 0.073 Stabilizing 0.816 D 0.695 prob.neutral None None None None N
T/M 0.1535 likely_benign 0.2866 benign 0.054 Stabilizing 0.997 D 0.759 deleterious None None None None N
T/N 0.2609 likely_benign 0.3915 ambiguous -0.818 Destabilizing 0.77 D 0.659 neutral N 0.51559787 None None N
T/P 0.5948 likely_pathogenic 0.8357 pathogenic -0.263 Destabilizing 0.96 D 0.791 deleterious N 0.51585136 None None N
T/Q 0.5198 ambiguous 0.7073 pathogenic -0.604 Destabilizing 0.969 D 0.799 deleterious None None None None N
T/R 0.4579 ambiguous 0.676 pathogenic -0.443 Destabilizing 0.94 D 0.796 deleterious None None None None N
T/S 0.1072 likely_benign 0.1248 benign -1.146 Destabilizing 0.043 N 0.291 neutral N 0.469720142 None None N
T/V 0.1867 likely_benign 0.29 benign -0.263 Destabilizing 0.69 D 0.6 neutral None None None None N
T/W 0.8753 likely_pathogenic 0.9627 pathogenic -0.761 Destabilizing 0.997 D 0.767 deleterious None None None None N
T/Y 0.5416 ambiguous 0.7905 pathogenic -0.388 Destabilizing 0.99 D 0.801 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.